相似文献
1
Heparin as an Analgesic in Myocardial Infarction: A Double-blind Trial.
Br Med J. 1967 Jul 29;3(5560):279-81. doi: 10.1136/bmj.3.5560.279.
2
TIMI 11B. Enoxaparin versus unfractionated heparin for unstable angina or non-Q-wave myocardial infarction: a double-blind, placebo-controlled, parallel-group, multicenter trial. Rationale, study design, and methods. Thrombolysis in Myocardial Infarction (TIMI) 11B Trial Investigators.
Am Heart J. 1998 Jun;135(6 Pt 3 Su):S353-60. doi: 10.1016/s0002-8703(98)70265-0.
3
Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a randomised trial. Organisation to Assess Strategies for Ischemic Syndromes (OASIS-2) Investigators.
Lancet. 1999 Feb 6;353(9151):429-38.
4
Trial of heparin versus atenolol in prevention of myocardial infarction in intermediate coronary syndrome.
Lancet. 1981 Jun 6;1(8232):1225-8. doi: 10.1016/s0140-6736(81)92399-0.
5
Thrombolysis with recombinant unglycosylated single-chain urokinase-type plasminogen activator (saruplase) in acute myocardial infarction: influence of heparin on early patency rate (LIMITS study). Liquemin in Myocardial Infarction During Thrombolysis With Saruplase.
J Am Coll Cardiol. 1995 Aug;26(2):365-73. doi: 10.1016/0735-1097(95)80008-5.
6
Bivalirudin as a replacement for unfractionated heparin in unstable angina/non-ST-elevation myocardial infarction: observations from the TIMI 8 trial. The Thrombolysis in Myocardial Infarction.
Am Heart J. 2002 Feb;143(2):229-34. doi: 10.1067/mhj.2002.120405.
7
One-year outcomes with abciximab and unfractionated heparin versus bivalirudin during percutaneous coronary interventions in patients with non-ST-segment elevation myocardial infarction: updated results from the ISAR-REACT 4 trial.
EuroIntervention. 2013 Aug 22;9(4):430-6. doi: 10.4244/EIJV9I4A71.
8
Randomized, double-blind comparison of hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO). Hirulog Early Reperfusion/Occlusion (HERO) Trial Investigators.
Circulation. 1997 Oct 7;96(7):2155-61. doi: 10.1161/01.cir.96.7.2155.
9
Cost-effectiveness of enoxaparin compared with unfractionated heparin in ST elevation myocardial infarction patients undergoing pharmacological reperfusion: a Canadian analysis of the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment - Thrombolysis in Myocardial Infarction (ExTRACT-TIMI) 25 trial.
Can J Cardiol. 2009 Dec;25(12):e399-405. doi: 10.1016/s0828-282x(09)70532-x.
10
Early thrombolytic treatment reduces analgesic requirement in patients with myocardial infarction.
J Intern Med. 1991 Mar;229(3):257-9. doi: 10.1111/j.1365-2796.1991.tb00341.x.
本文引用的文献
1
Virtue of prompt anticoagulant therapy in impending myocardial infarction: experiences with 318 patients during a 10-year period.
Ann Intern Med. 1959 May;50(5):1158-73. doi: 10.7326/0003-4819-50-5-1158.
2
Vascular effects of heparin, dextran sulphate, and 5-hydroxytryptamine.
Clin Sci. 1958 Nov;17(4):621-8.
Zotero 插件